Inavolisib: An Isoform-Selective Mutant PI3Ka Monovalent Degrader with Positive Ph. III Data
inavolisib
isoform-selective mutant PI3Kα degrader oral <9 mg QD, Ph. III in HR+/HER2- BC from cellular characterization of PI3Ki and opt. J. Med. Chem., December 1, 2022 Genentech, South San Francisco, CA
Loading...
